Safety of high-dose intravitreal triamcinolone acetonide as low-cost alternative to anti-vascular endothelial growth factor agents in lower-middle-income countries

par Ghoraba HH, Leila M, Elgouhary SM, Elgemai EEM, Abdelfattah HM, Ghoraba HH, Heikal MA
Publié 2018

Cost-effectiveness Analysis Comparing Vonoprazanbased Triple Therapy with Proton Pump Inhibitorbased Therapy in the Treatment of Helicobacter pylori Infection in Thailand

par Jadesada Lertsirimunkong, Wiwat Thavornwattanayong, Yosita Napuk, Watcharapong Ajcharoen, Vipavee Chaisitsanguan, Supasuta Wachiranukornkul
Publié 2021

The impact and cost-effectiveness of 9-valent human papillomavirus vaccine in adolescent females in Hong Kong

par Tak Hong Cheung, Sally Shuk Yee Cheng, Danny C. Hsu, Queenie Wing-Lei Wong, Andrew Pavelyev, Anuj Walia, Kunal Saxena, Vimalanand S. Prabhu
Publié 2021

Optimal surveillance strategies for patients with stage 1 cutaneous melanoma post primary tumour excision: three systematic reviews and an economic model

par Luke Vale, Patience Kunonga, Diarmuid Coughlan, Vasileios Kontogiannis, Margaret Astin, Fiona Beyer, Catherine Richmond, Dor Wilson, Dalvir Bajwa, Mehdi Javanbakht, Andrew Bryant, Wanwuri Akor, Dawn Craig, Penny Lovat, Marie Labus, Batoul Nasr, Timothy Cunliffe, Helena Hinde, Mohamed Shawgi, Daniel Saleh, Pam Royle, Paul Steward, Rachel Lucas, Robert Ellis
Publié 2021

Economic Evaluations of Interventions to Optimize Medication Use in Older Adults with Polypharmacy and Multimorbidity: A Systematic Review

par Laberge M, Sirois C, Lunghi C, Gaudreault M, Nakamura Y, Bolduc C, Laroche ML
Publié 2021

Cost-effectiveness of video-observed therapy for ambulatory management of active tuberculosis during the COVID-19 pandemic in a high-income country

par Ginenus Fekadu, Xinchan Jiang, Jiaqi Yao, Joyce H.S. You
Publié 2021

Pharmacoeconomic aspects of the treatment of diabetic foot syndrome

par Marina Fedorovna Kalashnikova, Nadezhda Viktorovna Maksimova, Oleg Viktorovich Udovichenko, Yury Ivanovich Suntsov
Publié 2010

High Human Papillomavirus Vaccine Acceptability and Cost-Effectiveness of the Chinese 2-Valent Vaccine Among Men Who Have Sex With Men: A Cross-Sectional Study in Shenyang, China

par Ze-Hao Ye, Ze-Hao Ye, Ze-Hao Ye, Ze-Hao Ye, Zhao-Zhen Liu, Zhao-Zhen Liu, Zhao-Zhen Liu, Zhao-Zhen Liu, Si-Tong Cui, Si-Tong Cui, Si-Tong Cui, Si-Tong Cui, Zhen-Xing Chu, Zhen-Xing Chu, Zhen-Xing Chu, Zhen-Xing Chu, Yong-Jun Jiang, Yong-Jun Jiang, Yong-Jun Jiang, Yong-Jun Jiang, Jun-Jie Xu, Jun-Jie Xu, Jun-Jie Xu, Jun-Jie Xu, Qing-Hai Hu, Qing-Hai Hu, Qing-Hai Hu, Qing-Hai Hu, Hong Shang, Hong Shang, Hong Shang, Hong Shang
Publié 2021

Cost-Effectiveness of the COVID-19 Test, Trace and Isolate Program in Colombia

par Yenny Guzmán Ruiz, Andres I. Vecino-Ortiz, Nicolás Guzman-Tordecilla, Rolando Enrique Peñaloza-Quintero, Julián A. Fernández-Niño, Maylen Rojas-Botero, Fernando Ruiz Gomez, Sean D. Sullivan, Antonio J. Trujillo
Publié 2022

Methotrexate (MTX) Plus Hydroxychloroquine versus MTX Plus Leflunomide in Patients with MTX-Resistant Active Rheumatoid Arthritis: A 2-Year Cohort Study in Real World

par Zhang L, Chen F, Geng S, Wang X, Gu L, Lang Y, Li T, Ye S
Publié 2020

Current Knowledge and Attitudes Concerning Cost-Effectiveness in Glaucoma Pharmacotherapy: A Glaucoma Specialists Focus Group Study

par Feldman RM, Cioffi GA, Liebmann JM, Weinreb RN
Publié 2020

A Systematic Review of Cost-Effectiveness Analyses of Novel Agents in the Treatment of Multiple Myeloma

par Maarten R. Seefat, David G. J. Cucchi, Stijn Dirven, Kaz Groen, Sonja Zweegman, Hedwig M. Blommestein
Publié 2021

Cost-effectiveness of Tamoxifen, Aromatase Inhibitor, and Switch Therapy (Adjuvant Endocrine Therapy) for Breast Cancer in Hormone Receptor Positive Postmenopausal Women in India

par Butani D, Gupta N, Jyani G, Bahuguna P, Kapoor R, Prinja S
Publié 2021

Life-cycle data envelopment analysis to measure efficiency and cost-effectiveness of environmental regulation in China’s transport sector

par Fan Yang, Yongrok Choi, Hyoungsuk Lee
Publié 2021

Comparing the cost-effectiveness of two screening strategies for latent tuberculosis infection in Portugal

par Sofia Sousa, Diogo Rocha, Joelma C. Silva, Ana Isabel Ribeiro, Guilherme Gonçalves, Álvaro Almeida, Ana Maria Correia, Raquel Duarte, Carlos Carvalho
Publié 2021

Outbreak and control of Foot and Mouth Disease within and across adjacent districts—A mathematical perspective

par Ivan Sseguya, Joseph Y.T. Mugisha, Betty Nannyonga
Publié 2022

Two decades with omalizumab: what we still have to learn

par Incorvaia C, Mauro M, Makri E, Leo G, Ridolo E
Publié 2018

Cost-effectiveness and value of information analysis of NephroCheck and NGAL tests compared to standard care for the diagnosis of acute kidney injury

par Elisabet Jacobsen, Simon Sawhney, Miriam Brazzelli, Lorna Aucott, Graham Scotland, Magaly Aceves-Martins, Clare Robertson, Mari Imamura, Amudha Poobalan, Paul Manson, Callum Kaye, Dwayne Boyers
Publié 2021

Using non-vitamin K oral anticoagulants in specific patient populations: a study of Korean cases

par Cho IY
Publié 2019

An overview of health technology assessments of gene therapies with the focus on cost-effectiveness models

par Michał Pochopień, Ewelina Paterak, Emilie Clay, Justyna Janik, Samuel Aballea, Małgorzata Biernikiewicz, Mondher Toumi
Publié 2021